Search 

HealthiosXchange is the premier online capital market dedicated exclusively to the global healthcare industry. Employing “Crowdfunding” as the cornerstone of a new paradigm in healthcare investing, the H/X offers direct access from "seed" to "exit" to the most promising healthcare companies on a “No Fee No Carry” basis. 

Healthios, the founder of HealthiosXchange, is a boutique investment bank dedicated exclusively to the global healthcare industry: 

- The most compelling growth companies 
- The most dynamic industry sectors 
- The most sophisticated institutional investors 
- The most active strategic buyers and partners 

Healthios seeks to be the premier investment bank serving the global healthcare industry by combining the experience of (52) transactions in 17 countries with unique access to capital, resources and ideas that are the foundation of superior value.

Financing, Partnering, Capital Markets, M&A

Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and NASDAQ 100® Indexes, Henry Schein employs more than 18,000 Team Schein Members and serves more than one million customers. 
The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and Henry Schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services. 
Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 30 countries. The Company's sales reached a record $10.4 billion in 2014, and have grown at a compound annual rate of approximately 16 percent since Henry Schein became a public company in 1995.

For more information, visit the Henry Schein website at www.henryschein.com

HSS is nationally ranked #1 in orthopedics, and #3 in rheumatology by U.S.News & World Report (2015-16). HSS has been top-ranked for both orthopedics and rheumatology for the 24 consecutive years.

Because an infection can be a devastating outcome for an orthopedic patient, Hospital for Special Surgery takes infection control extremely seriously and is proud of the recognition received for our significantly low infection rates. 

HSS and a complement of physicians within each specialty area accepts most major insurance plans. Our Insurance Advisory Service can answer questions regarding your insurance coverage.

HSS is nationally ranked #1 in orthopedics, and #3 in rheumatology by U.S.News & World Report (2015-16). HSS has been top-ranked for both orthopedics and rheumatology for the 24 consecutive years.

Because an infection can be a devastating outcome for an orthopedic patient, Hospital for Special Surgery takes infection control extremely seriously and is proud of the recognition received for our significantly low infection rates. 

HSS and a complement of physicians within each specialty area accepts most major insurance plans. Our Insurance Advisory Service can answer questions regarding your insurance coverage.

The Icahn School of Medicine at Mount Sinai is an international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for the Mount Sinai Health System, which includes seven hospital campuses, and has more than 5,000 faculty and nearly 2,000 students, residents and fellows. Our unwavering pursuit of intellectual exchange, breakthrough research, and multidisciplinary teamwork propels us ever forward in biomedical discoveries and advances. We pursue ideas that often challenge conventional wisdom to revolutionize the practice of medicine and produce dramatically better outcomes for patients. We make big, bold bets by investing in radical free thinkers and technology at the cutting edge.